Author Archive | Charles Bieneman

Lessons from the USPTO’s Patent Quality Symposium

The USPTO is working in a number of ways to emphasize clarity in patent prosecution.  That is the clear theme emerging from the USPTO’s Patent Quality Symposium, which I attended in Alexandria on April 27, 2016.  In listening to the various presentations, I was struck that this emphasis – on clarity of the record and […]

Continue Reading

Does Claim Construction Matter in Determining Patent-Eligibility under 35 U.S.C. § 101?

Patent applicants and owners should position claims for narrow constructions where subject matter is susceptible to challenge under 35 U.S.C. § 101, suggests a recent decision from the USPTO’s Patent Trial and Appeal Board (PTAB).  In a Covered Business Method (CBM) review Final Written Decision, the PTAB held that claims of U.S. Patent No. 8,402,281, […]

Continue Reading

How Did the Supreme Court’s Akamai Decision Change the Law of Divided Patent Infringement?

The Federal Circuit has given new life to a patent owner alleging that actions of multiple parties constitute direct infringement under 35 U.S.C. § 271(a).  Mankes v. Vivid Seats Ltd., No 15-1500 (Fed. Cir. April 22, 2016).  The patent owner had alleged direct infringement of its patent by parties who carried out only some and […]

Continue Reading

Plaintiff Stuck with Collateral Judgment of Patent Invalidity Under Alice in More Ways Than One

Not only did collateral estoppel apply from a prior finding of patent invalidity under 35 U.S.C. § 101, but a plaintiff was denied a motion to voluntarily dismiss its claim of patent infringement, the court expressly leaving open the specter of a fee award to the defendant as a prevailing party under 35 U.S.C. § […]

Continue Reading

Patent Claims to Collecting Website Feedback Not a “Financial Product or Service,” Do Not Qualify for CBM Review, Says PTAB

Patent claims reciting subject matter that, among other applications, could be used in the financial industry, do not qualify for Covered Business Method (CBM) review, said the USPTO’s Patent Trial and Appeal Board in Qualtrics, LLC v. OpinionLab, Inc., Case CBM2016-00003 (PTAB April 13, 2016).  Claims of U.S. Patent No. 8,041,805 were directed to collecting […]

Continue Reading

PTAB Reverses Patent-Eligibility Rejection of Business Method Implemented in a Vending Machine

Contrary to what some might think, the Patent Trial and Appeal Board (PTAB) does not always affirm rejections under 35 U.S.C. § 101, as evidenced by its recent decision in Ex parte Krampe, Appeal 2013-010784; Appl. No. 12/653,741; Technology Center 3600 (March 31, 2016).  In this case, the PTAB held that the Examiner had failed […]

Continue Reading

Claims Drawn to Monitoring and Analyzing Network Data Held Patent-Eligible

Claims drawn to “enterprise network” monitoring and analysis are patent-eligible, according to Delaware’s Judge Sue Robinson, who denied the defendant’s motion for Summary Judgment of invalidity under 35 U.S.C. § 101 in SRI International Inc. v. Cisco Systems Inc., No. 1:2013cv01534 (D. Del. April 11, 2016).  Some people – including many patent examiners – will […]

Continue Reading

How Do Biotech Patent-Eligibility Cases Speak to Computer Patent-Eligibility Cases?

The Federal Circuit recently held that a claim of U.S. Patent No. 5,612,179, reciting “methods of detecting genetic variations” was directed to unpatentable subject matter under 35 U.S.C. § 101.  Genetic Technologies Ltd. V. Merial, LLC, Nos. 2015-1202, 2015-1203 (Fed. Cir. April 8, 2016).  Anytime the Federal Circuit weighs in on Section 101 patent-eligibility, those […]

Continue Reading

Powered by WordPress. Designed by WooThemes